Decrease in serum prolactin by naloxone: evidence against antidopamine and antipsychotic effects.
D000818:Animals; D006220:Haloperidol / Q000494:pharmacology; D000882:Haplorhini; D006801:Humans; D008251:Macaca; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology*; D009293:Opioid-Related Disorders / Q000097:blood; D011388:Prolactin / Q000097:blood*; D011618:Psychotic Disorders / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects*
D011954:Receptors, Dopamine; D009270:Naloxone; D009020:Morphine; D011388:Prolactin; D006220:Haloperidol; D008691:Methadone